180 Life Sciences Corp (ATNF)
1.87
-0.13
(-6.50%)
USD |
NASDAQ |
May 06, 16:00
1.98
+0.11
(+5.88%)
After-Hours: 20:00
180 Life Sciences Shareholders Equity (Quarterly): -0.1277M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.1277M |
| September 30, 2023 | -0.1493M |
| June 30, 2023 | 6.716M |
| March 31, 2023 | 7.140M |
| December 31, 2022 | 11.34M |
| September 30, 2022 | 26.08M |
| June 30, 2022 | 42.79M |
| Date | Value |
|---|---|
| March 31, 2022 | 40.90M |
| December 31, 2021 | 39.32M |
| September 30, 2021 | 37.14M |
| June 30, 2021 | 2.716M |
| March 31, 2021 | 22.71M |
| December 31, 2020 | 30.29M |
| December 31, 2019 | 38.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.1493M
Minimum
Sep 2023
42.79M
Maximum
Jun 2022
21.82M
Average
24.39M
Median
Shareholders Equity (Quarterly) Benchmarks
| Seelos Therapeutics Inc | -33.51M |
| Altimmune Inc | 194.10M |
| GT Biopharma Inc | 7.476M |
| Outlook Therapeutics Inc | -24.34M |
| MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.260M |
| Total Liabilities (Quarterly) | 5.387M |